Gene: VSIG10
Official Full Name: V-set and immunoglobulin domain containing 10provided by HGNC
Gene Summary: Predicted to enable cell adhesion molecule binding activity. Predicted to be involved in cell-cell adhesion. Predicted to be located in membrane. Predicted to be active in cell-cell junction and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21584 | VSIG10 Knockout cell line (HeLa) | Human | VSIG10 | 1:3~1:6 | Negative | Online Inquiry |
KO21585 | VSIG10 Knockout cell line (HCT 116) | Human | VSIG10 | 1:2~1:4 | Negative | Online Inquiry |
KO21586 | VSIG10 Knockout cell line (HEK293) | Human | VSIG10 | 1:3~1:6 | Negative | Online Inquiry |
KO21587 | VSIG10 Knockout cell line (A549) | Human | VSIG10 | 1:3~1:4 | Negative | Online Inquiry |
VSIG10 Gene Knockout Cell Lines are specialized cellular models that have been genetically engineered to lack the expression of the VSIG10 gene, a protein implicated in various physiological processes and disease mechanisms. These knockout cell lines serve as powerful tools that allow researchers to investigate the functional role of VSIG10, facilitating a deeper understanding of its contribution to cell signaling pathways and immune responses.
The key functions of VSIG10, a member of the immunoglobulin superfamily, include its involvement in modulating both T-cell activation and B-cell response. By utilizing the VSIG10 knockout cell lines, researchers can elucidate the mechanisms by which VSIG10 influences cellular behaviors, including proliferation, differentiation, and apoptosis under both normal and pathological conditions. This functional analysis is crucial for identifying potential therapeutic targets in autoimmune diseases and cancers where dysregulation of immune responses is observed.
The scientific importance of these knockout cell lines is profound; they enable high-resolution studies into the gene's role in diseases, which can lead to the development of novel treatment strategies. In clinical settings, the insights gained from research utilizing these cell lines can inform the development of biomarker-based diagnostics and personalized medicine approaches.
Compared to alternative models that only partially mimic genetic silencing, VSIG10 Gene Knockout Cell Lines provide a complete loss-of-function scenario, presenting an unparalleled accuracy in reflecting the biological roles of the target gene. This precision is essential for generating reproducible data in research.
For researchers and clinicians navigating the complex landscape of immunology and molecular biology, the use of VSIG10 Gene Knockout Cell Lines represents an invaluable resource that enhances experimental rigor and accelerates discovery. By investing in our products, users gain access to high-quality, carefully validated cellular models backed by our commitment to excellence in biotechnological innovation. Our expertise in cell line development ensures that researchers can rely on our offerings to further their investigative pursuits with confidence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.